The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmid a period of steady demand in the healthcare sector, Recordati reported solid financial performance for the first half of 2026. According to reports, consolidated net revenue reached €1,410.8 million, marking a 6.6% increase compared to the previous period. The company's EBITDA rose by 8.8% to reach €540.2 million, which represents 38.3% of its net revenue.
The growth was primarily driven by continued momentum in the group's core business segments, which achieved a 9.1% increase when measured at constant exchange rates. However, these gains were partially offset by a negative currency impact totaling €34.5 million during the first half of the year. Adjusted net income also saw an upward trajectory, growing by 6.7% to reach €349.9 million.
Investors are monitoring the company's ability to maintain margin expansion in the face of ongoing currency volatility. While specific market price levels for RECORDATI were unavailable at the time of reporting, the solid operational performance suggests a stable outlook for the remainder of the fiscal year. Future catalysts will depend on the group's ability to sustain its core segment momentum and mitigate foreign exchange risks.